Stryker pays $15M fine in a DOJ Settlement after Unapproved OP-1 Clinical Study

         Stryker Reaches Settlement with the U.S. Attorney's Office (press release) Kalamazoo, Michigan - January 18, 2012 - Stryker Corporation (NYSE:SYK) announced today that Stryker Biotech has reached a settlement with the U.S. Attorney's Office for the District of Massachusetts.  As part of the settlement, Stryker has agreed to plead to one misdemeanor charge and pay a non-tax deductible fine of $15 million. As a result of this resolution, the Department of Justice has agreed to dismiss all thirteen felony charges against Stryker Biotech contained in a 2009 federal grand ju...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top